RSS
8 May 2023

Inhibikase Therapeutics to Report First Quarter Financial Results on May 15, 2023

Author: admintech | Filed under: Press Release

BOSTON and ATLANTA, May 8, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease, Parkinson’s-related disorders and…

This entry was posted on Monday, May 8th, 2023 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»